Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6 – March 29, 2021

Abstract

Introduction Previous studies suggested that almost one-third of U.S. adults did not plan to get a COVID-19 vaccine once it is available to them. The purpose of this study was to examine changes in vaccine intentions and attitudes by sociodemographic characteristics and geographic areas, factors associated with vaccination intent, and reasons for non-vaccination among a nationally representative sample of U.S. adults. Methods Data from six waves of the Household Pulse Survey (6 January – 29 March 2021) were analyzed. Differences between January and March were assessed using t -tests. Factors associated with vaccination intent were examined in multivariable logistic regression models. Results From early January to late March, vaccination receipt of ≥1 dose of the COVID-19 vaccine or intention to definitely get vaccinated increased from 54.7 to 72.3%; however, disparities in vaccination intent continued to exist by age group, race/ethnic groups, and socioeconomic characteristics. Vaccine receipt and the intent were the lowest for region 4 (southeastern U.S.) throughout this period. Adults who had a previous COVID-19 diagnosis or were unsure if they have had COVID-19 were less likely to intend to get vaccinated [prevalence ratio = 0.92 (95%CI: 0.90–0.93) and 0.80 (95%CI: 0.74–0.85), respectively]. The belief that a vaccine is not needed increased by more than five percentage points from early January to late March. Conclusion Intent to definitely get a COVID-19 vaccine increased by almost 18 percentage points from early January to late March; however, younger adults, adults who are non-Hispanic Black or other races, adults of lower socioeconomic status, and adults living in the southeastern U.S. region (Region 4) continue to have higher coverage gaps and levels of vaccine hesitancy. Emphasizing the importance of vaccination among all populations, and removing barriers to vaccines, may lead to a reduction of COVID-19 incidence and bring an end to the pandemic. KEY MESSAGES Receipt of ≥1 dose of the COVID-19 vaccine and intent to probably or definitely get vaccinated increased from early January to late March; however, disparities in vaccine intent continued to exist by age group, race/ethnic groups, and socioeconomic characteristics. Vaccine receipt and the intent were the lowest for region 4 (southeastern U.S.) compared to other regions during this period. Adults who had a previous COVID-19 diagnosis or were unsure if they have had COVID-19 were less likely to intend to get vaccinated; overall, the belief that a vaccine is not needed to be increased by more than 5% points from early January to late March.

Racial/ethnic disparities in intent to obtain a COVID-19 vaccine: A nationally representative United States survey

“…Recent data indicate that the proportion of U.S. adults who have received at least 1 dose (as of September/October 2021) ranges from 72% to 82% (CDC reports ages 12 and older) ( Centers for Disease Control and Prevention, 2020 , Hamel et al, 2021 , Survey, 2021 ), with Asian, American Indian/Alaska Native and Latino persons reporting the highest rates, depending on the source. In the scientific literature, recent estimates for adults who have received at least one dose range from 64% for Black to 86% for Asian persons (May 2021) ( Nguyen et al, 2021 ). One study examining adults ages 18–39 (March-May 2021) reported vaccination rates ranging from 25% among Black persons to 39% among those classified as from all other races ( Baack et al, 2021 ).…”

Trends in COVID-19 vaccination receipt and intention to vaccinate, United States, April to August, 2021

“…Furthermore, the re-opening of schools and businesses, and increased social gatherings and travel 4 , amplify the need for increased vaccination coverage. Unfortunately, even as vaccination coverage and intent increased from January to March 2021, disparities existed by age, race/ethnicity, and other sociodemographic factors 5 . To follow-up on these early vaccination disparities, the present study assessed trends and differences in vaccination coverage and intent from April to August 2021, and examined changes in reasons for not getting vaccinated using a large, nationally representative survey.…”

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

“… 2-4 Several vaccines that are highly effective in reducing the incidence of hospitalization and death have been authorized; however, vaccine coverage remains insufficient. 5 , 6 Antiviral therapies that reduce the risk of Covid-19 progression are needed. Since trials have shown the need for initiation of treatment as soon as possible after the onset of symptoms, 7-9 such therapies would ideally be readily available and easily administered by the patients themselves.…”